Scientific article
OA Policy
English

Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial

Published in

Critical care, vol. 19, 91

Publication date

2015

Abstract

A systemic anticoagulation is often required to prevent circuit and filter clotting in ICU patients undergoing continuous renal replacement therapy (CRRT). A regional citrate-based anticoagulation (RCA) does not induce a systemic anticoagulation and prolongs the filter lifespan, but metabolic side-effects have been associated with this therapy. We conducted a randomized controlled trial with patients requiring CRRT to determine whether RCA using a balanced predilution replacement fluid is more effective than heparin in terms of renal replacement delivered dose and safety profile.

Keywords

  • Acute Kidney Injury/drug therapy
  • Aged
  • Anticoagulants/therapeutic use
  • Blood Coagulation
  • Citrates/therapeutic use
  • Female
  • Filtration
  • Heparin/therapeutic use
  • Humans
  • Intensive Care Units
  • Male
  • Middle Aged
  • Renal Replacement Therapy/methods
  • Survival Rate

Citation (ISO format)

STUCKER, Fabien Jérôme et al. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial. In: Critical care, 2015, vol. 19, p. 91. doi: 10.1186/s13054-015-0822-z

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

1364-8535
641views
459downloads

Technical informations

Creation

24/11/2016 13:14:00

First validation

24/11/2016 13:14:00

Update

13/10/2025 20:29:04

Status update

15/03/2023 01:02:13

Last indexation

02/11/2026 10:18:12
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated